"$200,000.... [to] $300,000 a year"
Or are TAXPAYERS picking up the bill?
"Myozyme sales boost Genzyme profit" by Bloomberg News | February 12, 2009
Genzyme Corp., the world's largest maker of drugs for rare genetic disorders, said fourth-quarter profit rose 9.8 percent on sales of Myozyme for the rare genetic disorder Pompe disease.
Net income increased to $86.7 million....
I thought this was a rough economy, and yet every day in the business pages I'm seeing corporations making MILLIONS in PROFITS!
Genzyme's medicines treat rare hereditary disorders caused by lack of enzymes needed for critical body functions. The drugs are some of the world's costliest and include Cerezyme for Gaucher disease and Aldurazyme for a condition called MPS1. Both cost about $200,000 a year.
Myozyme, the company's fastest-growing product, costs about $300,000 a year. Genzyme awaits US regulatory approval to expand production of the drug....
--more--"
FDA Protects Big Pharma While Telling Americans "F*** You!"
FDA Doesn't Care About Cancer
FDA Approval to Immunize Drug Companies From Lawsuits
